30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

NuVasive Reports Preliminary 4Q16 and 2016 Revenue -

NuVasive announced preliminary unaudited 2016 sales of ~US $956.0MM, +17.9% from 2015, with 4Q16 revenue of ~$265.0MM. 

For 2017, the company announced full-year guidance of ~$1.0BB, +11.4% from 2016. 

Source: NuVasive, Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.